A biohacker who spends a whopping $2 million a year to ‘live forever’ has left people shocked after sharing his and his son’s ‘erection data’.
Bryan Johnson is taking part in a lengthy and intense experimental medical program in the hope of ‘reversing aging’.
Whether it be following a strict diet, or using his son’s blood, the biohacker is doing everything in his power to retain the status of youth.
Johnson has previously said his mission has helped him achieve the ‘heart of 37-year-old’ and the ‘lung capacity of an 18-year-old, but it certainly hasn’t been easy.
As his wild mission continues and many more people learn about his story through Netflix’s Don’t Die: The Man Who Wants to Live Forever, Johnson has shared a piece of data no one on the internet would have ever expected to be coming their way.
The biohacker took to Twitter on Wednesday (January 22) to share ‘erection data’ from both him and his son, Talmage.
Yep, certainly a piece of data I didn’t expect to be reading this morning.
Accompanying the data, Johnson wrote: “Nighttime erection data from my 19-year-old son, @talmagejohnson_, and me. His duration is two minutes longer than mine. Raise children to stand tall, be firm, and be upright.”
The data included the pair’s sleep efficiency, average erection quality, number of erection episodes and total duration.
Johnson achieved a better average erection quality with 94, while his son received a slightly lower 90 score.
The biohacker also had much better sleep efficiency but had one less erection episode compared to Talmage.
As you’d probably expect, many were left curious as to how Johnson measured the study, with one person asking: “Did I ask how you track this? I don’t think I have this activated on my Apple Watch.”
Johnson has previously said he used a sensor to measure the data.
Quoting tweeting his dad’s post, Talmage wrote: “I’m grateful for the way my dad has raised me.”
While he’s been on his own mission to look young, Johnson gave his then 70-year-old father some of his plasma in what he hailed as ‘the world’s first multigenerational plasma exchange’.
Plasma infusions are usually used to treat a variety of conditions, including liver disease, burns, and blood disorders, rather than for age-reversing purposes.
Using the procedure for reasons such as age reversal is not advised by the FDA.
The authority said in a 2019 statement: “The FDA has recently become aware of reports of establishments in several states that are offering infusions of plasma from young donors to purportedly treat the effects of a variety of conditions.
“The conditions range from normal aging and memory loss to serious diseases like dementia, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, heart disease or post-traumatic stress disorder.
“We have significant public health concerns about the promotion and use of plasma for these purposes. There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated with the use of any plasma product.”